Pharma Reaserch Prod Co Ltd (214450) — Financial Flexibility Index
Pharma Reaserch Prod Co Ltd (214450) has a Financial Flexibility Index of 0.22x as of December 2025. Free cash flow of ₩69.31 Billion (operating CF ₩61.53 Billion minus capex ₩7.79 Billion) represents 0% of total liabilities (₩320.01 Billion). Check total reinvestment intensity of Pharma Reaserch Prod Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pharma Reaserch Prod Co Ltd Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Pharma Reaserch Prod Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see 214450 cash generation efficiency.
Annual Financial Flexibility Index for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year free cash flow to debt coverage for Pharma Reaserch Prod Co Ltd. Explore 214450 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | ₩218.94 Billion | ₩183.16 Billion | ₩320.01 Billion | ▲ +9.7% |
| 2024 | 0.62x | ₩178.60 Billion | ₩139.88 Billion | ₩286.26 Billion | ▼ -41.6% |
| 2023 | 1.07x | ₩78.14 Billion | ₩64.95 Billion | ₩73.09 Billion | ▲ +86.4% |
| 2022 | 0.57x | ₩77.16 Billion | ₩59.40 Billion | ₩134.55 Billion | ▼ -18.5% |
| 2021 | 0.70x | ₩85.94 Billion | ₩65.30 Billion | ₩122.20 Billion | ▼ -22.1% |
| 2020 | 0.90x | ₩67.18 Billion | ₩32.39 Billion | ₩74.41 Billion | ▲ +90.4% |
| 2019 | 0.47x | ₩28.86 Billion | ₩19.27 Billion | ₩60.85 Billion | ▼ -15.0% |
| 2018 | 0.56x | ₩33.80 Billion | ₩5.20 Billion | ₩60.56 Billion | ▼ -64.9% |
| 2017 | 1.59x | ₩16.19 Billion | ₩8.56 Billion | ₩10.18 Billion | ▲ +20.8% |
| 2016 | 1.32x | ₩10.12 Billion | ₩8.16 Billion | ₩7.69 Billion | ▲ +0.2% |
| 2015 | 1.31x | ₩16.49 Billion | ₩16.02 Billion | ₩12.56 Billion | — |